AGP ban boosts probiotics market

Probiotics represent one of the most promising alternatives to antimicrobials
developed in recent years to protect animal health and increase the efficiency
of nutrient utilisation. Probiotics have been demonstrated to have an equivalent
efficacy to synthetic antimicrobial growth promoters (AGP), which were
previously used as prophylactics to suppress growth and activity in all gut
microflora species, before they were banned completely in Europe in January
2006.

Growth in monogastric feed market
In particular, the
antimicrobial ban has left the EU monogastric animal feed industry at a
financial disadvantage, as it competes with countries outside the EU that can
still use in-feed antimicrobials to protect against diseases such as scour and
necrotic enteritis. Accordingly, the animal feed probiotics market is poised for
growth. In monogastric animals especially, the use of probiotics can help to
reduce the significant increase in therapeutic antimicrobials administered since
the antimicrobial ban. Moreover, the imminent ban on AGP in the United States is
expected to augment the growth potential of the European animal feed probiotics
market in the next five years.

Efficacy and reliability
The
strategic positioning of feed additive products to target specific production
problems or periods of stress will become more important and the choice of
strain may increasingly become affected by changes in feed composition or
quality. Although the acceptability of probiotics has risen in the last few
years, concerns still exist regarding their efficacy and reliability. Hence,
increasing end-user confidence in these products is
essential.

Related website:
Summary of the report:
Strategic Analysis of the European Animal Feed Probiotics Market


Related folder:
Dossier AllAbout Probiotics

To receive the AllAboutFeed newsletter click
here.

(Source: Businesswire.com)